211 related articles for article (PubMed ID: 29297170)
1. Deciding the Duration of Adjuvant Chemotherapy in a Patient With Stage III Colon Cancer: When Can Less Be More?
Trivedi ND; Marshall JL
Oncology (Williston Park); 2017 Dec; 31(12):863-5, 871, 884. PubMed ID: 29297170
[No Abstract] [Full Text] [Related]
2. PRODIGE 34-FFCD 1402-ADAGE: Adjuvant chemotherapy in elderly patients with resected stage III colon cancer: A randomized phase 3 trial.
Aparicio T; Francois E; Cristol-Dalstein L; Carola E; Maillard E; Paillaud E; Retornaz F; Faroux R; André T; Bedenne L; Seitz JF
Dig Liver Dis; 2016 Feb; 48(2):206-7. PubMed ID: 26748426
[No Abstract] [Full Text] [Related]
3. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
4. Current stages of adjuvant treatment of colon cancer.
Köhne CH
Ann Oncol; 2012 Sep; 23 Suppl 10():x71-6. PubMed ID: 22987996
[No Abstract] [Full Text] [Related]
5. Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J; Tabernero J; Mini E; Subtil F; Folprecht G; Van Laethem JL; Thaler J; Bridgewater J; Petersen LN; Blons H; Collette L; Van Cutsem E; Rougier P; Salazar R; Bedenne L; Emile JF; Laurent-Puig P; Lepage C;
Lancet Oncol; 2014 Jul; 15(8):862-73. PubMed ID: 24928083
[TBL] [Abstract][Full Text] [Related]
6. Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
Lu CS; Chang PY; Chen YG; Chen JH; Wu YY; Ho CL
PLoS One; 2015; 10(9):e0138632. PubMed ID: 26382962
[TBL] [Abstract][Full Text] [Related]
7. Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.
Kumar A; Peixoto RD; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Speers CH; Cheung WY
Clin Colorectal Cancer; 2015 Dec; 14(4):262-8.e1. PubMed ID: 26123496
[TBL] [Abstract][Full Text] [Related]
8. The wide gulf between stage III and stage IV colon cancer.
Ting DT; Ryan DP
Lancet Oncol; 2014 Jul; 15(8):785-6. PubMed ID: 24928084
[No Abstract] [Full Text] [Related]
9. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
10. [Progression of adjuvant chemotherapy for colon cancer].
He YJ; Dong QM; Li YH
Ai Zheng; 2005 Dec; 24(12):1546-9. PubMed ID: 16351811
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy: Adding oxaliplatin to the equation.
Benson AB
Nat Rev Clin Oncol; 2009 Nov; 6(11):620-2. PubMed ID: 19861991
[No Abstract] [Full Text] [Related]
13. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
14. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
[TBL] [Abstract][Full Text] [Related]
15. [II. Postoperative adjuvant chemotherapy for colon cancer. 1. Is oxaliplatin combination the most effective chemotherapy for colon cancer?].
Sato T; Nakamura T; Naitou M; Ogura N; Miura H; Tsutsui A; Watanabe M
Gan To Kagaku Ryoho; 2012 Nov; 39(11):1642-. PubMed ID: 23243701
[No Abstract] [Full Text] [Related]
16. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy for colon cancer: the US experience.
Haller DG
Tumori; 2001; 87(1 Suppl 1):S86-8. PubMed ID: 11300040
[No Abstract] [Full Text] [Related]
18. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
19. Highlights from: The 45th Annual Meeting of the American Society of Clinical Oncology.
Cig Media Group LP
Clin Colorectal Cancer; 2009 Jul; 8(3):128-34. PubMed ID: 19632926
[No Abstract] [Full Text] [Related]
20. Effect of a Shortened Duration of FOLFOX Chemotherapy on the Survival Rate of Patients with Stage II and III Colon Cancer.
Ji WB; Hong KD; Kim JS; Joung SY; Um JW; Min BW
Chemotherapy; 2018; 63(1):8-12. PubMed ID: 29130943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
